… imaging approaches for diagnostic localization of endocrine tumors, with emphasis on positron
emission tomography (… is now a widely accepted imaging approach in clinical oncology. …

… We evaluated the clinical value of positron emission tomography (PET) using 18F-fluorodeoxyglucose
(FDG) for neuroendocrine tumor (NET) detection. Sixteen patients with …

… to obtain images that simultaneously hold both anatomic (… tomography [CT]) and functional
(single-photon emission computed tomography [SPECT] or positron emission tomography […

… Purpose: 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) is currently
not used on a routine basis for imaging of neuroendocrine (NE) tumors. The aim of this study …

… studies showed that 68 Ga-DOTATOC or other somatostatin receptor related peptides such
as DOTANOC are superior to DOPA in imaging of typical neuroendocrine tumors. However, …

… imaging modality for NETs that has been found to be more sensitive for NET detection than
other imaging … -DOTATATE positron emission tomography/computed tomography for the …

… The past decade has seen an increasing clinical utilization of positron emission tomography
(PET), such that it is now considered a standard oncology imaging modality. Integrated PET/…

… When we compared 68 Ga-DOTATATE PET/CT imaging to surgical histopathology in a
per-lesion analysis, we found true positive lesions in 72 of 113 lesions (63.7%), in 25 of 113 …

… of positron emission tomography (PET) with carbon-1 -labeled 5-HTP in the diagnosis and
treatment follow-up evaluation of patients with neuroendocrine tumors. … two functional imaging …

… of fluorine-18 FDG positron emission tomography (PET) with that of somato… neuroendocrine
tumours. Fifteen patients with metastasizing gastroenteropancreatic tumours (GEP tumours; …